{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:09:34Z","timestamp":1757617774126,"version":"3.44.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00467-025-06772-8","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T06:04:55Z","timestamp":1745906695000},"page":"3077-3080","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical differences between female monozygotic twins with X-linked Alport syndrome with somatic mosaicism"],"prefix":"10.1007","volume":"40","author":[{"given":"Naoaki","family":"Mikami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kitakado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-459X","authenticated-orcid":false,"given":"Riku","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"6772_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/ndt\/gfae182","volume":"40","author":"R Suzuki","year":"2024","unstructured":"Suzuki R, Sakakibara N, Murakami S, Ichikawa Y, Kitakado H, Ueda C, Tanaka Y, Okada E, Kondo A, Aoto Y, Ishiko S, Ishimori S, Nagano C, Yamamura T, Horinouchi T, Okamoto T, Nozu K (2024) Genotype and X-chromosome inactivation are associated with disease severity in females with X-linked Alport syndrome. Nephrol Dial Transplant 40:688\u2013695","journal-title":"Nephrol Dial Transplant"},{"key":"6772_CR2","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1002\/mgg3.647","volume":"7","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Ding J, Zhang H, Yao Y, Xiao H, Wang S, Wang F (2019) Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome. Mol Genet Genomic Med 7:e647","journal-title":"Mol Genet Genomic Med"},{"key":"6772_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10157-016-1352-y","volume":"21","author":"K Yokota","year":"2017","unstructured":"Yokota K, Nozu K, Minamikawa S, Yamamura T, Nakanishi K, Kaneda H, Hamada R, Nozu Y, Shono A, Ninchoji T, Morisada N, Ishimori S, Fujimura J, Horinouchi T, Kaito H, Nakanishi K, Morioka I, Taniguchi-Ikeda M, Iijima K (2017) Female X-linked Alport syndrome with somatic mosaicism. Clin Exp Nephrol 21:877\u2013883","journal-title":"Clin Exp Nephrol"},{"key":"6772_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ejhg.2015.113","volume":"24","author":"XJ Fu","year":"2016","unstructured":"Fu XJ, Nozu K, Kaito H, Ninchoji T, Morisada N, Nakanishi K, Yoshikawa N, Ohtsubo H, Matsunoshita N, Kamiyoshi N, Matsumura C, Takagi N, Maekawa K, Taniguchi-Ikeda M, Iijima K (2016) Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome. Eur J Hum Genet 24:387\u2013391","journal-title":"Eur J Hum Genet"},{"key":"6772_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41588-020-00755-1","volume":"53","author":"H Jonsson","year":"2021","unstructured":"Jonsson H, Magnusdottir E, Eggertsson HP, Stefansson OA, Arnadottir GA, Eiriksson O, Zink F, Helgason EA, Jonsdottir I, Gylfason A, Jonasdottir A, Jonasdottir A, Beyter D, Steingrimsdottir T, Norddahl GL, Magnusson OT, Masson G, Halldorsson BV, Thorsteinsdottir U, Helgason A, Sulem P, Gudbjartsson DF, Stefansson K (2021) Differences between germline genomes of monozygotic twins. Nat Genet 53:27\u201334","journal-title":"Nat Genet"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06772-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06772-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06772-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:59:10Z","timestamp":1757163550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06772-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["6772"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06772-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have obtained written consent from the patient\u2019s parents for the publication of the content of this report and any associated supplementary material.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Kandai Nozu is a member of an advisory group for Kyowa Kirin Co. Ltd., Toa Eiyo LTD., Zenyaku Kogyo Co. Ltd., and Taisho Pharmaceutical Co. Ltd. and has a patent for developing exon skipping therapy for Alport syndrome. Kandai Nozu has also received lecture fees from Ono Pharma, Astellas Pharma, Novo Nordisk Pharma, Sumitomo Pharma, Sanofi, Otsuka Pharma, Daiichi Sankyo, and Miyarisan and a grant from Zenyaku Kogyo and Torii Co. Ltd. The other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}